Anti-Human CD61 (Integrin β3) (Clone F11) – PE
Anti-Human CD61 (Integrin β3) (Clone F11) – PE
Product No.: C194
- -
- -
Clone F11 Target CD61 Formats AvailableView All Product Type Monoclonal Antibody Alternate Names Integrin β3 Isotype IgG1 Applications FC |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Product Concentration 0.2 mg/ml Formulation This R-phycoerythrin (R-PE) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. Storage and Handling This R-PE conjugate is stable when stored at 2-8°C. Do not freeze. Country of Origin USA Shipping Next Day 2-8°C Excitation Laser Blue Laser (488 nm) and/or Green Laser (532 nm)/Yellow-Green Laser (561 nm) RRIDAB_2829021 Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Mouse Anti-Human CD61 (Clone F11) recognizes Human CD61. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Anti-CD61 recognizes the (Mr 110 kDa) common ß-subunit of the gp IIb/IIIa complex and the vitronectin receptor (VNR). The gp IIb (CD41) antigen and the gp IIIa (CD61) antigen form the cell adhesion complex (gp IIb/IIIa) which is the receptor on platelets for fibrinogen, von Willebrand factor, fibronectin and vitronectin. Background Anti-CD61 can be used to identify platelets and megakaryocytes. It may also be used to characterize leukemias and in studies of cell adhesion molecules. Antigen Distribution The CD61 antigen is present on virtually all resting and activated platelets. The antigen is also known to be present on endothelial cells, megakaryocytes and some leukemias of myeloid, erythroid and lymphoid origin. Ligand/Receptor Fibronectin, vitronectin, vWF PubMed NCBI Gene Bank ID UniProt.org Research Area Immunology References & Citations1. Helfrich, M. N. et al. submitted for publication
Phycobilliproteins are protected under the following patents: (U.S. patents No. 4,520,110 and 4,542,104, European patent no. 76695, Canadian patent No. 1,179,942 and Australian patent No. 548,440).
Technical ProtocolsCertificate of Analysis |
Related Products
Formats Available
- -
- -
Prod No. | Description |
---|---|
C1822 | |
C191 | |
C192 | |
C193 | |
C1814 | |
C1815 | |
C1816 | |
C1818 | |
C1820 | |
C194 | |
C327 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.